Manufacturer record
Everest Pharmaceuticals Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Everest Pharmaceuticals Ltd was declared Not of Standard Quality in February 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 22VC 1 03A, Ventoxen (Venetoclax) Tablets 100 mg (exp Apr 2024). RDTL Chandigarh (CDSCO lab) found it not of standard quality: Identification and Assay of Venetoclax. Listed in the February 2023 alert.
Records by type
1 record linked to Everest Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ventoxen (Venetoclax) Tablets 100 mg | Batch 22VC 1 03AMfg May 2022 · Exp Apr 2024 | Identification and Assay of VenetoclaxAssay | RDTL ChandigarhCDSCO lab | Feb 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.